CAS 80830-42-8: Fentiapril
Formula:C13H15NO4S2
InChI:InChI=1S/C13H15NO4S2/c15-10-4-2-1-3-8(10)12-14(11(16)5-6-19)9(7-20-12)13(17)18/h1-4,9,12,15,19H,5-7H2,(H,17,18)/t9-,12+/m0/s1
InChI key:InChIKey=BSHDUMDXSRLRBI-JOYOIKCWSA-N
SMILES:O=C(O)C1N(C(=O)CCS)C(SC1)C=2C=CC=CC2O
- Synonyms:
- (2R,4R)-2-(2-Hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-4-thiazolidinecarboxylic acid
- (2R,4R)-2-(2-hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid
- (2R,4R)-2-(o-Hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid
- 4-Thiazolidinecarboxylic acid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-, (2R,4R)-
- 4-Thiazolidinecarboxylic acid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-, (2R-cis)-
- Brn 5762860
- Ccris 2341
- Fentiapril
- Prescrin
- Rentiapril [INN]
- See more synonyms
- Rentiaprilum
- Rentiaprilum [Latin]
- Sa 446
- Sa 466
- Unii-D0Tam1017B
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Rentiapril REF: 3D-FDA83042CAS: 80830-42-8 | Min. 95% | To inquire | Mon 14 Apr 25 |
![]() | Rentiapril REF: TM-T12704CAS: 80830-42-8 | 98% | 113.00 €~1,768.00 € | Mon 21 Apr 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Rentiapril
CAS:80830-42-8
Rentiapril is a pharmaceutical drug that belongs to the group of angiotensin-converting enzyme (ACE) inhibitors. …
Formula:
C13H15NO4S2
Purity:
Min. 95%
Molecular weight:
313.4 g/mol
Ref: 3D-FDA83042
25mg | 1,217.00 € | ||
50mg | 1,692.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Rentiapril
CAS:80830-42-8
Rentiapril is an orally active inhibitor of angiotensin converting enzyme (ACE), with antihypertensive activity.
Formula:
C13H15NO4S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
313.39
Ref: TM-T12704
5mg | 283.00 € | ||
25mg | 938.00 € | ||
50mg | 1,293.00 € | ||
100mg | 1,768.00 € | ||
1mL*10mM (DMSO) | 303.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025